Accrued Expenses & Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Payables and Accruals [Abstract]

Schedule of Accrued Expenses & Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	DECEMBER 31,
(in thousands)	2021		2020
Accrued expenses and other current liabilities:
Accrued compensation and benefits	$	15,881	$	15,207
Accrued consulting and professional fees	5,007		2,645
Accrued research and development (1)	2,262		2,222
Accrued revenue reserves(2)	85,381		66,552
Accrued other(3)	3,810		4,097
Total accrued expenses and other current liabilities	$	112,341	$	90,723

(1)Comprised primarily of accruals related to fees for investigative sites, contract research organizations and other service providers that assist in conducting preclinical research studies and clinical trials.

(2)Comprised primarily of accruals related to commercial and government rebates as well as returns. The accrued revenue reserve at December 31, 2021 is higher than prior year primarily due to higher rebates largely driven by government sponsored programs.

(3)Comprised primarily of accruals related to interest payable as well as other business-related expenses.